FGF-5 Activators
Fibroblast Growth Factor 5 (FGF-5) is a crucial protein involved in regulating various cellular processes, particularly in embryonic development and tissue homeostasis. As a member of the fibroblast growth factor (FGF) family, FGF-5 plays a significant role in the regulation of cell proliferation, differentiation, and migration. Specifically, FGF-5 is implicated in the regulation of hair growth, where it acts as a negative regulator of hair follicle lengthening during the hair growth cycle. Its expression is predominantly observed in the hair follicles, where it exerts its inhibitory effects on hair growth by negatively modulating the activity of hair follicle stem cells and promoting the transition of hair follicles from the growth (anagen) phase to the resting (telogen) phase.
The activation of FGF-5 is orchestrated by various signaling pathways and mechanisms. One of the key mechanisms involves the interaction of FGF-5 with its cognate receptors, particularly the fibroblast growth factor receptors (FGFRs). Upon binding to its receptor, FGF-5 triggers downstream signaling cascades, including the mitogen-activated protein kinase (MAPK) pathway and the phosphoinositide 3-kinase (PI3K)/Akt pathway. These signaling pathways play crucial roles in mediating cellular responses such as cell proliferation, survival, and differentiation. Additionally, FGF-5 activation can be modulated by various extracellular factors and co-receptors, which fine-tune its activity in response to different physiological and environmental cues. Overall, the activation of FGF-5 is tightly regulated to ensure proper control of cellular processes, particularly in the context of hair growth regulation and tissue homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is a small molecule inhibitor of the TGF-β type I receptor and can potentially act as an indirect activator of FGF-5. By inhibiting the TGF-β signaling pathway, SB431542 can relieve the inhibitory effects of TGF-β1 on FGF-5. TGF-β1 is known to negatively regulate FGF-5 expression, and inhibition of its signaling can lead to increased FGF-5 activity, influencing cellular responses related to growth and differentiation. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
Trametinib is a MEK inhibitor that indirectly influences FGF-5 activity by blocking the MAPK/ERK pathway. As the MAPK/ERK pathway intersects with FGF-5 signaling, inhibition of MEK by Trametinib can potentially lead to increased FGF-5 activity. The activation of FGF-5 may occur as a consequence of the relief of negative feedback loops within the MAPK/ERK pathway, influencing cellular responses related to cell proliferation and differentiation. | ||||||
LY 364947 | 396129-53-6 | sc-203122 sc-203122A | 5 mg 10 mg | $107.00 $156.00 | 4 | |
LY364947 is a small molecule inhibitor of the TGF-β type I receptor and can potentially act as an indirect activator of FGF-5. By inhibiting the TGF-β signaling pathway, LY364947 can relieve the inhibitory effects of TGF-β1 on FGF-5. TGF-β1 negatively regulates FGF-5 expression, and inhibition of its signaling can lead to increased FGF-5 activity, influencing cellular responses related to growth and differentiation. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $202.00 $811.00 | 16 | |
A83-01 is a TGF-β type I receptor inhibitor that can potentially act as an indirect activator of FGF-5. By inhibiting the TGF-β signaling pathway, A83-01 can relieve the inhibitory effects of TGF-β1 on FGF-5. TGF-β1 negatively regulates FGF-5 expression, and inhibition of its signaling can lead to increased FGF-5 activity, influencing cellular responses related to growth and differentiation. | ||||||
GW788388 | 452342-67-5 | sc-363544 sc-363544A | 5 mg 25 mg | $95.00 $384.00 | ||
GW788388 is a TGF-β type I receptor inhibitor that can potentially act as an indirect activator of FGF-5. By inhibiting the TGF-β signaling pathway, GW788388 can relieve the inhibitory effects of TGF-β1 on FGF-5. TGF-β1 negatively regulates FGF-5 expression, and inhibition of its signaling can lead to increased FGF-5 activity, influencing cellular responses related to growth and differentiation. | ||||||
PD 184,352 | 212631-79-3 | sc-202759 sc-202759A | 1 mg 5 mg | $40.00 $260.00 | 34 | |
PD 184,352 (CI-1040) is a MEK inhibitor that indirectly influences FGF-5 activity by blocking the MAPK/ERK pathway. As the MAPK/ERK pathway intersects with FGF-5 signaling, inhibition of MEK by CI-1040 can potentially lead to increased FGF-5 activity. The activation of FGF-5 may occur as a consequence of the relief of negative feedback loops within the MAPK/ERK pathway, influencing cellular responses related to cell proliferation and differentiation. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $213.00 $359.00 | 3 | |
LY2157299 is a TGF-β type I receptor inhibitor that can potentially act as an indirect activator of FGF-5. By inhibiting the TGF-β signaling pathway, LY2157299 can relieve the inhibitory effects of TGF-β1 on FGF-5. TGF-β1 negatively regulates FGF-5 expression, and inhibition of its signaling can lead to increased FGF-5 activity, influencing cellular responses related to growth and differentiation. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $29.00 $82.00 $420.00 $1897.00 $3021.00 | 5 | |
Selumetinib is a MEK inhibitor that indirectly influences FGF-5 activity by blocking the MAPK/ERK pathway. As the MAPK/ERK pathway intersects with FGF-5 signaling, inhibition of MEK by Selumetinib can potentially lead to increased FGF-5 activity. The activation of FGF-5 may occur as a consequence of the relief of negative feedback loops within the MAPK/ERK pathway, influencing cellular responses related to cell proliferation and differentiation. | ||||||